A Randomized, Double-blind, Double-dummy, Parallel-group, Placebo Controlled (on Inhaled Corticosteroid Medication), Multicenter Study to Evaluate the Efficacy and Safety of Vilanterol Inhalation Powder (GW642444) and Salmeterol, Compared With Placebo in the Treatment of Persistent Asthma in Adults and Adolescents Uncontrolled on Inhaled Corticosteroids
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Vilanterol (Primary) ; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 28 Apr 2012 Planned number of patients changed from 336 to 347 as reported by European Clinical Trials Database.
- 28 Apr 2012 Official title amended as reported by European Clinical Trials Database.
- 09 Jan 2012 Primary endpoint 'Forced-expiratory-volume-in-1-second' has not been met, according to a GlaxoSmithKline and Theravance media release.